BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 807699 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(C)O InChI=1S/C21H25N5O3/c1-14-8-9-15(17-12-19(29-24-17)21(2,3)28)13-25(14)20(27)16-6-4-5-7-18(16)26-22-10-11-23-26/h4-7,10-12,14-15,28H,8-9,13H2,1-3H3/t14-,15-/m1/s1 DNGHIQGLHKSAIM-HUUCEWRRSA-N 404256 (1 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-5-yl}propan-2-ol)::US10017504, 1 Orexin receptor type 2 Homo sapiens 46.9 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404256&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315869 406795024 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807700 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(C)O InChI=1S/C21H25N5O3/c1-14-8-9-15(17-12-19(29-24-17)21(2,3)28)13-25(14)20(27)16-6-4-5-7-18(16)26-22-10-11-23-26/h4-7,10-12,14-15,28H,8-9,13H2,1-3H3/t14-,15-/m1/s1 DNGHIQGLHKSAIM-HUUCEWRRSA-N 404256 (1 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-5-yl}propan-2-ol)::US10017504, 1 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404256&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315869 406795024 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807701 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(on1)C(C)(C)O InChI=1S/C23H27N3O3/c1-15-8-9-16(19-12-20(29-25-19)22(2,3)28)13-26(15)21(27)17-6-4-5-7-18(17)23(14-24)10-11-23/h4-7,12,15-16,28H,8-11,13H2,1-3H3/t15-,16-/m1/s1 FCDLBGIPKWCXLZ-HZPDHXFCSA-N 404257 (1-(2-((2R,5R)-5-(5-(2-Hydroxypropan-2-yl)isoxazol-3-yl)-2-methylpiperidine-1-carbonyl)phenyl)cyclopropanecarbonitrile)::US10017504, 2 Orexin receptor type 2 Homo sapiens 104 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404257&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315947 406795025 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807702 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(on1)C(C)(C)O InChI=1S/C23H27N3O3/c1-15-8-9-16(19-12-20(29-25-19)22(2,3)28)13-26(15)21(27)17-6-4-5-7-18(17)23(14-24)10-11-23/h4-7,12,15-16,28H,8-11,13H2,1-3H3/t15-,16-/m1/s1 FCDLBGIPKWCXLZ-HZPDHXFCSA-N 404257 (1-(2-((2R,5R)-5-(5-(2-Hydroxypropan-2-yl)isoxazol-3-yl)-2-methylpiperidine-1-carbonyl)phenyl)cyclopropanecarbonitrile)::US10017504, 2 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404257&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315947 406795025 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807703 C[C@@H]1CC[C@H](CN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1cc(on1)C(C)(C)O InChI=1S/C21H24ClN5O3/c1-13-4-5-14(17-11-19(30-25-17)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-18(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 PAEQVNGCFWZPAY-ZIAGYGMSSA-N 404259 (5-Chloro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-5-(5-(2-hydroxypropan-2- yl)isoxazol-3-yl)-2-methylpiperidin-1- yl)methanone::US10017504, 3 Orexin receptor type 2 Homo sapiens 1427 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404259&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305869 406795027 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807704 C[C@@H]1CC[C@H](CN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1cc(on1)C(C)(C)O InChI=1S/C21H24ClN5O3/c1-13-4-5-14(17-11-19(30-25-17)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-18(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 PAEQVNGCFWZPAY-ZIAGYGMSSA-N 404259 (5-Chloro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-5-(5-(2-hydroxypropan-2- yl)isoxazol-3-yl)-2-methylpiperidin-1- yl)methanone::US10017504, 3 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404259&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305869 406795027 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807705 C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-n1nccn1)c1cc(on1)C(C)(C)O InChI=1S/C21H24FN5O3/c1-13-4-5-14(17-11-19(30-25-17)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-18(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 CYWSZBJBWPJIID-ZIAGYGMSSA-N 404264 (5-Fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-5-(5-(2-hydroxypropan-2- yl)isoxazol-3-yl)-2-methylpiperidin-1- yl)methanone::US10017504, 4 Orexin receptor type 2 Homo sapiens 278 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404264&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305889 406795030 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807706 C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-n1nccn1)c1cc(on1)C(C)(C)O InChI=1S/C21H24FN5O3/c1-13-4-5-14(17-11-19(30-25-17)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-18(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 CYWSZBJBWPJIID-ZIAGYGMSSA-N 404264 (5-Fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)((2R,5R)-5-(5-(2-hydroxypropan-2- yl)isoxazol-3-yl)-2-methylpiperidin-1- yl)methanone::US10017504, 4 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404264&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305889 406795030 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807707 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(on1)C(C)(C)O InChI=1S/C21H28N2O4/c1-5-26-18-9-7-6-8-16(18)20(24)23-13-15(11-10-14(23)2)17-12-19(27-22-17)21(3,4)25/h6-9,12,14-15,25H,5,10-11,13H2,1-4H3/t14-,15-/m1/s1 NNVRYMAVSLEJJV-HUUCEWRRSA-N 404266 ((2-Ethoxyphenyl)((2R,5R)-5-(5-(2-hydroxypropan-2-yl)isoxazol-3-yl)-2-methylpiperidin-1-yl)methanone::US10017504, 5 Orexin receptor type 2 Homo sapiens 1193 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404266&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315971 406795032 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807708 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(on1)C(C)(C)O InChI=1S/C21H28N2O4/c1-5-26-18-9-7-6-8-16(18)20(24)23-13-15(11-10-14(23)2)17-12-19(27-22-17)21(3,4)25/h6-9,12,14-15,25H,5,10-11,13H2,1-4H3/t14-,15-/m1/s1 NNVRYMAVSLEJJV-HUUCEWRRSA-N 404266 ((2-Ethoxyphenyl)((2R,5R)-5-(5-(2-hydroxypropan-2-yl)isoxazol-3-yl)-2-methylpiperidin-1-yl)methanone::US10017504, 5 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404266&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315971 406795032 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807709 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(on1)C(C)(C)O InChI=1S/C21H29N3O4/c1-13(2)27-19-16(7-6-10-22-19)20(25)24-12-15(9-8-14(24)3)17-11-18(28-23-17)21(4,5)26/h6-7,10-11,13-15,26H,8-9,12H2,1-5H3/t14-,15-/m1/s1 KQOAVKCMRUHGAH-HUUCEWRRSA-N 404267 (((2R,5R)-5-(5-(2-Hydroxypropan-2-yl)isoxazol-3-yl)-2-methylpiperidin-1-yl)(2-isopropoxypyridin-3-yl)methanone)::US10017504, 6 Orexin receptor type 2 Homo sapiens 1840 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404267&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121316009 406795033 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807710 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(on1)C(C)(C)O InChI=1S/C21H29N3O4/c1-13(2)27-19-16(7-6-10-22-19)20(25)24-12-15(9-8-14(24)3)17-11-18(28-23-17)21(4,5)26/h6-7,10-11,13-15,26H,8-9,12H2,1-5H3/t14-,15-/m1/s1 KQOAVKCMRUHGAH-HUUCEWRRSA-N 404267 (((2R,5R)-5-(5-(2-Hydroxypropan-2-yl)isoxazol-3-yl)-2-methylpiperidin-1-yl)(2-isopropoxypyridin-3-yl)methanone)::US10017504, 6 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404267&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121316009 406795033 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807711 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)c1cc(on1)C(C)(C)O InChI=1S/C20H24F3N3O4/c1-12-6-7-13(15-9-16(30-25-15)19(2,3)28)10-26(12)18(27)14-5-4-8-24-17(14)29-11-20(21,22)23/h4-5,8-9,12-13,28H,6-7,10-11H2,1-3H3/t12-,13-/m1/s1 SCRRBUYJAVGDAF-CHWSQXEVSA-N 404268 ((2R,5R)-5-(5-(2-Hydroxypropan-2- yl)isoxazol-3-yl)-2-methylpiperidin-1- yl)(2-(2,2,2-trifluoroethoxy)pyridin-3- yl)methanone::US10017504, 7 Orexin receptor type 2 Homo sapiens 227 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404268&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305899 406795034 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807712 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)c1cc(on1)C(C)(C)O InChI=1S/C20H24F3N3O4/c1-12-6-7-13(15-9-16(30-25-15)19(2,3)28)10-26(12)18(27)14-5-4-8-24-17(14)29-11-20(21,22)23/h4-5,8-9,12-13,28H,6-7,10-11H2,1-3H3/t12-,13-/m1/s1 SCRRBUYJAVGDAF-CHWSQXEVSA-N 404268 ((2R,5R)-5-(5-(2-Hydroxypropan-2- yl)isoxazol-3-yl)-2-methylpiperidin-1- yl)(2-(2,2,2-trifluoroethoxy)pyridin-3- yl)methanone::US10017504, 7 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404268&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305899 406795034 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807713 CCC(O)(CC)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H29N5O3/c1-4-23(30,5-2)21-14-19(26-31-21)17-11-10-16(3)27(15-17)22(29)18-8-6-7-9-20(18)28-24-12-13-25-28/h6-9,12-14,16-17,30H,4-5,10-11,15H2,1-3H3/t16-,17-/m1/s1 NLMWRULCYTWFST-IAGOWNOFSA-N 404269 (2-(2H-1,2,3-Triazol-2-yl)phenyl)((2R,5R)-5-(5-(3-hydroxypentan-3-yl)isoxazol-3-yl)-2-methylpiperidin-1-yl)methanone)::US10017504, 8 Orexin receptor type 2 Homo sapiens 552 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404269&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305900 406795035 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807714 CCC(O)(CC)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H29N5O3/c1-4-23(30,5-2)21-14-19(26-31-21)17-11-10-16(3)27(15-17)22(29)18-8-6-7-9-20(18)28-24-12-13-25-28/h6-9,12-14,16-17,30H,4-5,10-11,15H2,1-3H3/t16-,17-/m1/s1 NLMWRULCYTWFST-IAGOWNOFSA-N 404269 (2-(2H-1,2,3-Triazol-2-yl)phenyl)((2R,5R)-5-(5-(3-hydroxypentan-3-yl)isoxazol-3-yl)-2-methylpiperidin-1-yl)methanone)::US10017504, 8 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404269&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305900 406795035 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807715 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C1CC1 InChI=1S/C23H27N5O3/c1-15-7-8-16(19-13-21(31-26-19)23(2,30)17-9-10-17)14-27(15)22(29)18-5-3-4-6-20(18)28-24-11-12-25-28/h3-6,11-13,15-17,30H,7-10,14H2,1-2H3/t15-,16-,23?/m1/s1 PHMWJTAIUSPTKN-LHVRJDQKSA-N 404274 US10017504, 10::US10017504, 9 Orexin receptor type 2 Homo sapiens 25.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404274&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315953 406795039 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807716 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C1CC1 InChI=1S/C23H27N5O3/c1-15-7-8-16(19-13-21(31-26-19)23(2,30)17-9-10-17)14-27(15)22(29)18-5-3-4-6-20(18)28-24-11-12-25-28/h3-6,11-13,15-17,30H,7-10,14H2,1-2H3/t15-,16-,23?/m1/s1 PHMWJTAIUSPTKN-LHVRJDQKSA-N 404274 US10017504, 10::US10017504, 9 Orexin/Hypocretin receptor type 1 Homo sapiens 7965 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404274&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315953 406795039 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807717 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C1CC1 InChI=1S/C23H27N5O3/c1-15-7-8-16(19-13-21(31-26-19)23(2,30)17-9-10-17)14-27(15)22(29)18-5-3-4-6-20(18)28-24-11-12-25-28/h3-6,11-13,15-17,30H,7-10,14H2,1-2H3/t15-,16-,23?/m1/s1 PHMWJTAIUSPTKN-LHVRJDQKSA-N 404274 US10017504, 10::US10017504, 9 Orexin receptor type 2 Homo sapiens 15.6 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404274&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315953 406795039 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807718 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C1CC1 InChI=1S/C23H27N5O3/c1-15-7-8-16(19-13-21(31-26-19)23(2,30)17-9-10-17)14-27(15)22(29)18-5-3-4-6-20(18)28-24-11-12-25-28/h3-6,11-13,15-17,30H,7-10,14H2,1-2H3/t15-,16-,23?/m1/s1 PHMWJTAIUSPTKN-LHVRJDQKSA-N 404274 US10017504, 10::US10017504, 9 Orexin/Hypocretin receptor type 1 Homo sapiens 2860 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404274&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315953 406795039 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807719 CC[C@@](C)(O)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-18(25-30-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-19(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22-/m1/s1 WUQIKHJVPQKMFW-XCGNWRKASA-N 404278 US10017504, 11 Orexin receptor type 2 Homo sapiens 41.4 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404278&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344745 406795042 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807720 CC[C@@](C)(O)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-18(25-30-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-19(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22-/m1/s1 WUQIKHJVPQKMFW-XCGNWRKASA-N 404278 US10017504, 11 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404278&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344745 406795042 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807721 CC[C@](C)(O)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-18(25-30-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-19(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22+/m1/s1 WUQIKHJVPQKMFW-MCFFVMPBSA-N 404279 US10017504, 12 Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404279&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114442 406795043 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807722 CC[C@](C)(O)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-18(25-30-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-19(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22+/m1/s1 WUQIKHJVPQKMFW-MCFFVMPBSA-N 404279 US10017504, 12 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404279&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114442 406795043 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807723 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C1(O)CCC1 InChI=1S/C22H25N5O3/c1-15-7-8-16(18-13-20(30-25-18)22(29)9-4-10-22)14-26(15)21(28)17-5-2-3-6-19(17)27-23-11-12-24-27/h2-3,5-6,11-13,15-16,29H,4,7-10,14H2,1H3/t15-,16-/m1/s1 FISGJCWMDNTRGZ-HZPDHXFCSA-N 404280 (1-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-5-yl}cyclobutanol)::US10017504, 13 Orexin receptor type 2 Homo sapiens 635 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404280&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315932 406795044 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807724 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C1(O)CCC1 InChI=1S/C22H25N5O3/c1-15-7-8-16(18-13-20(30-25-18)22(29)9-4-10-22)14-26(15)21(28)17-5-2-3-6-19(17)27-23-11-12-24-27/h2-3,5-6,11-13,15-16,29H,4,7-10,14H2,1H3/t15-,16-/m1/s1 FISGJCWMDNTRGZ-HZPDHXFCSA-N 404280 (1-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-5-yl}cyclobutanol)::US10017504, 13 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404280&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315932 406795044 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807725 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C(F)(F)F InChI=1S/C21H22F3N5O3/c1-13-7-8-14(16-11-18(32-27-16)20(2,31)21(22,23)24)12-28(13)19(30)15-5-3-4-6-17(15)29-25-9-10-26-29/h3-6,9-11,13-14,31H,7-8,12H2,1-2H3/t13-,14-,20?/m1/s1 DVQKHGWUCNMHET-SYVYAKSWSA-N 404281 US10017504, 14 Orexin receptor type 2 Homo sapiens 34.9 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404281&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315975 406795045 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807726 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C(F)(F)F InChI=1S/C21H22F3N5O3/c1-13-7-8-14(16-11-18(32-27-16)20(2,31)21(22,23)24)12-28(13)19(30)15-5-3-4-6-17(15)29-25-9-10-26-29/h3-6,9-11,13-14,31H,7-8,12H2,1-2H3/t13-,14-,20?/m1/s1 DVQKHGWUCNMHET-SYVYAKSWSA-N 404281 US10017504, 14 Orexin/Hypocretin receptor type 1 Homo sapiens 3644 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404281&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315975 406795045 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807727 C[C@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C(F)(F)F InChI=1S/C21H22F3N5O3/c1-13-7-8-14(16-11-18(32-27-16)20(2,31)21(22,23)24)12-28(13)19(30)15-5-3-4-6-17(15)29-25-9-10-26-29/h3-6,9-11,13-14,31H,7-8,12H2,1-2H3/t13-,14+,20?/m0/s1 DVQKHGWUCNMHET-IODPJOFQSA-N 404282 US10017504, 15 Orexin receptor type 2 Homo sapiens 33.9 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404282&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146676327 406795046 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807728 C[C@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)C(C)(O)C(F)(F)F InChI=1S/C21H22F3N5O3/c1-13-7-8-14(16-11-18(32-27-16)20(2,31)21(22,23)24)12-28(13)19(30)15-5-3-4-6-17(15)29-25-9-10-26-29/h3-6,9-11,13-14,31H,7-8,12H2,1-2H3/t13-,14+,20?/m0/s1 DVQKHGWUCNMHET-IODPJOFQSA-N 404282 US10017504, 15 Orexin/Hypocretin receptor type 1 Homo sapiens 6826 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404282&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146676327 406795046 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807729 CC(C)C(C)(O)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H29N5O3/c1-15(2)23(4,30)21-13-19(26-31-21)17-10-9-16(3)27(14-17)22(29)18-7-5-6-8-20(18)28-24-11-12-25-28/h5-8,11-13,15-17,30H,9-10,14H2,1-4H3/t16-,17-,23?/m1/s1 SJIHDYMYGWGYTB-QVSFKUMNSA-N 404283 US10017504, 16 Orexin receptor type 2 Homo sapiens 24.3 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404283&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315941 406795047 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807730 CC(C)C(C)(O)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H29N5O3/c1-15(2)23(4,30)21-13-19(26-31-21)17-10-9-16(3)27(14-17)22(29)18-7-5-6-8-20(18)28-24-11-12-25-28/h5-8,11-13,15-17,30H,9-10,14H2,1-4H3/t16-,17-,23?/m1/s1 SJIHDYMYGWGYTB-QVSFKUMNSA-N 404283 US10017504, 16 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404283&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315941 406795047 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807731 CC(C)C(C)(O)c1cc(no1)[C@H]1CC[C@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H29N5O3/c1-15(2)23(4,30)21-13-19(26-31-21)17-10-9-16(3)27(14-17)22(29)18-7-5-6-8-20(18)28-24-11-12-25-28/h5-8,11-13,15-17,30H,9-10,14H2,1-4H3/t16-,17-,23?/m0/s1 SJIHDYMYGWGYTB-UYHNVOLQSA-N 404340 US10017504, 17 Orexin receptor type 2 Homo sapiens 24.5 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404340&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146676332 406795101 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807732 CC(C)C(C)(O)c1cc(no1)[C@H]1CC[C@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H29N5O3/c1-15(2)23(4,30)21-13-19(26-31-21)17-10-9-16(3)27(14-17)22(29)18-7-5-6-8-20(18)28-24-11-12-25-28/h5-8,11-13,15-17,30H,9-10,14H2,1-4H3/t16-,17-,23?/m0/s1 SJIHDYMYGWGYTB-UYHNVOLQSA-N 404340 US10017504, 17 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404340&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146676332 406795101 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807733 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)[C@](C)(O)C(F)F InChI=1S/C21H23F2N5O3/c1-13-7-8-14(16-11-18(31-26-16)21(2,30)20(22)23)12-27(13)19(29)15-5-3-4-6-17(15)28-24-9-10-25-28/h3-6,9-11,13-14,20,30H,7-8,12H2,1-2H3/t13-,14-,21+/m1/s1 GOXHNKAJZYGMFO-LKBUQDJMSA-N 404284 ((2S)-1,1-Difluoro-2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-5-yl}propan-2-ol)::US10017504, 18 Orexin receptor type 2 Homo sapiens 92.0 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404284&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121316088 406795048 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807734 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(on1)[C@](C)(O)C(F)F InChI=1S/C21H23F2N5O3/c1-13-7-8-14(16-11-18(31-26-16)21(2,30)20(22)23)12-27(13)19(29)15-5-3-4-6-17(15)28-24-9-10-25-28/h3-6,9-11,13-14,20,30H,7-8,12H2,1-2H3/t13-,14-,21+/m1/s1 GOXHNKAJZYGMFO-LKBUQDJMSA-N 404284 ((2S)-1,1-Difluoro-2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-5-yl}propan-2-ol)::US10017504, 18 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404284&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121316088 406795048 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807735 COC(C)(C)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-15-9-10-16(18-13-20(30-25-18)22(2,3)29-4)14-26(15)21(28)17-7-5-6-8-19(17)27-23-11-12-24-27/h5-8,11-13,15-16H,9-10,14H2,1-4H3/t15-,16-/m1/s1 IRCFHMLPZBLDAP-HZPDHXFCSA-N 404285 ((2R,5R)-5-[5-(1-Methoxy-1-methylethyl)isoxazol-3-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine)::US10017504, 19 Orexin receptor type 2 Homo sapiens 27.3 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404285&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315861 406795049 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807736 COC(C)(C)c1cc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-15-9-10-16(18-13-20(30-25-18)22(2,3)29-4)14-26(15)21(28)17-7-5-6-8-19(17)27-23-11-12-24-27/h5-8,11-13,15-16H,9-10,14H2,1-4H3/t15-,16-/m1/s1 IRCFHMLPZBLDAP-HZPDHXFCSA-N 404285 ((2R,5R)-5-[5-(1-Methoxy-1-methylethyl)isoxazol-3-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine)::US10017504, 19 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404285&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315861 406795049 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807737 CCOC(=O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N5O4/c1-3-29-21(28)17-12-19(30-24-17)15-9-8-14(2)25(13-15)20(27)16-6-4-5-7-18(16)26-22-10-11-23-26/h4-7,10-12,14-15H,3,8-9,13H2,1-2H3/t14-,15-/m1/s1 SNIPUMQDPPPVGR-HUUCEWRRSA-N 404286 (2-{5-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}propan-2-ol)::US10017504, 20 Orexin receptor type 2 Homo sapiens 30.3 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404286&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315999 406795050 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807738 CCOC(=O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H23N5O4/c1-3-29-21(28)17-12-19(30-24-17)15-9-8-14(2)25(13-15)20(27)16-6-4-5-7-18(16)26-22-10-11-23-26/h4-7,10-12,14-15H,3,8-9,13H2,1-2H3/t14-,15-/m1/s1 SNIPUMQDPPPVGR-HUUCEWRRSA-N 404286 (2-{5-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}propan-2-ol)::US10017504, 20 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404286&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315999 406795050 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807739 COCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C21H28N2O4/c1-14-9-10-15(18-11-19(22-27-18)21(2,3)25)12-23(14)20(24)17-8-6-5-7-16(17)13-26-4/h5-8,11,14-15,25H,9-10,12-13H2,1-4H3/t14-,15-/m1/s1 CRDRJZMUMCTTCO-HUUCEWRRSA-N 404288 (2-{5-[(3R,6R)-1-{[2-(Methoxymethyl)phenyl]carbonyl}-6-methylpiperidin-3-yl]isoxazol-3-yl}propan-2-ol)::US10017504, 21 Orexin receptor type 2 Homo sapiens 1121 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404288&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315863 406795051 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807740 COCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C21H28N2O4/c1-14-9-10-15(18-11-19(22-27-18)21(2,3)25)12-23(14)20(24)17-8-6-5-7-16(17)13-26-4/h5-8,11,14-15,25H,9-10,12-13H2,1-4H3/t14-,15-/m1/s1 CRDRJZMUMCTTCO-HUUCEWRRSA-N 404288 (2-{5-[(3R,6R)-1-{[2-(Methoxymethyl)phenyl]carbonyl}-6-methylpiperidin-3-yl]isoxazol-3-yl}propan-2-ol)::US10017504, 21 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404288&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315863 406795051 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807741 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(no1)C(C)(C)O InChI=1S/C23H26N4O3/c1-15-9-10-16(19-13-20(26-30-19)23(2,3)29)14-27(15)22(28)18-8-5-4-7-17(18)21-24-11-6-12-25-21/h4-8,11-13,15-16,29H,9-10,14H2,1-3H3/t15-,16-/m1/s1 LQJUMDUSBXWUPJ-HZPDHXFCSA-N 404289 2-(5-{(3R,6R)-6-Methyl-1-[(2- pyrimidin-2- ylphenyl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 22 Orexin receptor type 2 Homo sapiens 51.4 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404289&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305884 406795052 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807742 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(no1)C(C)(C)O InChI=1S/C23H26N4O3/c1-15-9-10-16(19-13-20(26-30-19)23(2,3)29)14-27(15)22(28)18-8-5-4-7-17(18)21-24-11-6-12-25-21/h4-8,11-13,15-16,29H,9-10,14H2,1-3H3/t15-,16-/m1/s1 LQJUMDUSBXWUPJ-HZPDHXFCSA-N 404289 2-(5-{(3R,6R)-6-Methyl-1-[(2- pyrimidin-2- ylphenyl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 22 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404289&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305884 406795052 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807743 CCOc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C20H27N3O4/c1-5-26-18-15(7-6-10-21-18)19(24)23-12-14(9-8-13(23)2)16-11-17(22-27-16)20(3,4)25/h6-7,10-11,13-14,25H,5,8-9,12H2,1-4H3/t13-,14-/m1/s1 ZUSUKYYEFVQQPM-ZIAGYGMSSA-N 404290 2-(5-{(3R,6R)-1-[(2- Ethoxypyridin-3-yl)carbonyl]-6- methylpiperidin-3-yl}isoxazol-3- yl)propan-2-ol::US10017504, 23 Orexin receptor type 2 Homo sapiens 268 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404290&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305862 406795053 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807744 CCOc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C20H27N3O4/c1-5-26-18-15(7-6-10-21-18)19(24)23-12-14(9-8-13(23)2)16-11-17(22-27-16)20(3,4)25/h6-7,10-11,13-14,25H,5,8-9,12H2,1-4H3/t13-,14-/m1/s1 ZUSUKYYEFVQQPM-ZIAGYGMSSA-N 404290 2-(5-{(3R,6R)-1-[(2- Ethoxypyridin-3-yl)carbonyl]-6- methylpiperidin-3-yl}isoxazol-3- yl)propan-2-ol::US10017504, 23 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404290&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305862 406795053 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807745 C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-n1nccn1)c1cc(no1)C(C)(C)O InChI=1S/C21H24FN5O3/c1-13-4-5-14(18-11-19(25-30-18)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-17(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 IFWAODBMWPPKNN-ZIAGYGMSSA-N 404291 2-{5-[(3R,6R)-1-{[5-Fluoro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isoxazol-3- yl}propan-2-ol::US10017504, 24 Orexin receptor type 2 Homo sapiens 215 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404291&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344732 406795054 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807746 C[C@@H]1CC[C@H](CN1C(=O)c1cc(F)ccc1-n1nccn1)c1cc(no1)C(C)(C)O InChI=1S/C21H24FN5O3/c1-13-4-5-14(18-11-19(25-30-18)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-17(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 IFWAODBMWPPKNN-ZIAGYGMSSA-N 404291 2-{5-[(3R,6R)-1-{[5-Fluoro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isoxazol-3- yl}propan-2-ol::US10017504, 24 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404291&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344732 406795054 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807747 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-n1cccn1)c1cc(no1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-5-6-14(15-11-16(24-29-15)20(2,3)28)12-25(13)19(27)17-18(22-9-8-21-17)26-10-4-7-23-26/h4,7-11,13-14,28H,5-6,12H2,1-3H3/t13-,14-/m1/s1 SXJMRFVAGBGIHB-ZIAGYGMSSA-N 404292 2-{5-[(3R,6R)-6-methyl-1-{[3- (1H-pyrazol-1-yl)pyrazin-2- yl]carbonyl}piperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 25 Orexin receptor type 2 Homo sapiens 799 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404292&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114435 406795055 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807748 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-n1cccn1)c1cc(no1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-5-6-14(15-11-16(24-29-15)20(2,3)28)12-25(13)19(27)17-18(22-9-8-21-17)26-10-4-7-23-26/h4,7-11,13-14,28H,5-6,12H2,1-3H3/t13-,14-/m1/s1 SXJMRFVAGBGIHB-ZIAGYGMSSA-N 404292 2-{5-[(3R,6R)-6-methyl-1-{[3- (1H-pyrazol-1-yl)pyrazin-2- yl]carbonyl}piperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 25 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404292&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114435 406795055 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807749 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ccccc1)c1cc(no1)C(C)(C)O InChI=1S/C25H28N2O3/c1-17-13-14-19(22-15-23(26-30-22)25(2,3)29)16-27(17)24(28)21-12-8-7-11-20(21)18-9-5-4-6-10-18/h4-12,15,17,19,29H,13-14,16H2,1-3H3/t17-,19-/m1/s1 VHOGBPHESIEQLR-IEBWSBKVSA-N 404293 2-{5-[(3R,6R)-1-(Biphenyl-2- ylcarbonyl)-6-methylpiperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 26 Orexin receptor type 2 Homo sapiens 22.9 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404293&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344728 406795056 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807750 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ccccc1)c1cc(no1)C(C)(C)O InChI=1S/C25H28N2O3/c1-17-13-14-19(22-15-23(26-30-22)25(2,3)29)16-27(17)24(28)21-12-8-7-11-20(21)18-9-5-4-6-10-18/h4-12,15,17,19,29H,13-14,16H2,1-3H3/t17-,19-/m1/s1 VHOGBPHESIEQLR-IEBWSBKVSA-N 404293 2-{5-[(3R,6R)-1-(Biphenyl-2- ylcarbonyl)-6-methylpiperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 26 Orexin/Hypocretin receptor type 1 Homo sapiens 1808 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404293&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344728 406795056 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807751 C[C@@H]1CC[C@H](CN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1cc(no1)C(C)(C)O InChI=1S/C21H24ClN5O3/c1-13-4-5-14(18-11-19(25-30-18)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-17(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 GADZZMKYKAUNCQ-ZIAGYGMSSA-N 404294 2-{5-[(3R,6R)-1-{[5-Chloro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isoxazol-3- yl}propan-2-ol::US10017504, 27 Orexin receptor type 2 Homo sapiens 604 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404294&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344742 406795057 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807752 C[C@@H]1CC[C@H](CN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1cc(no1)C(C)(C)O InChI=1S/C21H24ClN5O3/c1-13-4-5-14(18-11-19(25-30-18)21(2,3)29)12-26(13)20(28)16-10-15(22)6-7-17(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 GADZZMKYKAUNCQ-ZIAGYGMSSA-N 404294 2-{5-[(3R,6R)-1-{[5-Chloro-2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isoxazol-3- yl}propan-2-ol::US10017504, 27 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404294&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344742 406795057 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807753 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-c1ccccn1)c1cc(no1)C(C)(C)O InChI=1S/C22H25N5O3/c1-14-7-8-15(17-12-18(26-30-17)22(2,3)29)13-27(14)21(28)20-19(24-10-11-25-20)16-6-4-5-9-23-16/h4-6,9-12,14-15,29H,7-8,13H2,1-3H3/t14-,15-/m1/s1 VKVXENOTEIHFKG-HUUCEWRRSA-N 404295 2-(5-{(3R,6R)-6-Methyl-1-[(3- pyridin-2-ylpyrazin-2- yl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 28 Orexin receptor type 2 Homo sapiens 1421 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404295&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305873 406795058 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807754 C[C@@H]1CC[C@H](CN1C(=O)c1nccnc1-c1ccccn1)c1cc(no1)C(C)(C)O InChI=1S/C22H25N5O3/c1-14-7-8-15(17-12-18(26-30-17)22(2,3)29)13-27(14)21(28)20-19(24-10-11-25-20)16-6-4-5-9-23-16/h4-6,9-12,14-15,29H,7-8,13H2,1-3H3/t14-,15-/m1/s1 VKVXENOTEIHFKG-HUUCEWRRSA-N 404295 2-(5-{(3R,6R)-6-Methyl-1-[(3- pyridin-2-ylpyrazin-2- yl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 28 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404295&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305873 406795058 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807755 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(no1)C(C)(C)O InChI=1S/C23H27N3O3/c1-15-8-9-16(19-12-20(25-29-19)22(2,3)28)13-26(15)21(27)17-6-4-5-7-18(17)23(14-24)10-11-23/h4-7,12,15-16,28H,8-11,13H2,1-3H3/t15-,16-/m1/s1 SHAVTPNLCUSUAY-HZPDHXFCSA-N 404296 1-[2-({(2R,5R)-5-[3-(1-Hydroxy- 1-methylethyl)isoxazol-5-yl]-2- methylpiperidin-1- yl}carbonyl)phenyl]cyclopropane carbonitrile::US10017504, 29 Orexin receptor type 2 Homo sapiens 8.80 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404296&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305886 406795059 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807756 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(no1)C(C)(C)O InChI=1S/C23H27N3O3/c1-15-8-9-16(19-12-20(25-29-19)22(2,3)28)13-26(15)21(27)17-6-4-5-7-18(17)23(14-24)10-11-23/h4-7,12,15-16,28H,8-11,13H2,1-3H3/t15-,16-/m1/s1 SHAVTPNLCUSUAY-HZPDHXFCSA-N 404296 1-[2-({(2R,5R)-5-[3-(1-Hydroxy- 1-methylethyl)isoxazol-5-yl]-2- methylpiperidin-1- yl}carbonyl)phenyl]cyclopropane carbonitrile::US10017504, 29 Orexin/Hypocretin receptor type 1 Homo sapiens 1900 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404296&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305886 406795059 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807757 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C21H26N2O5/c1-13-9-10-14(17-11-18(22-28-17)21(2,3)26)12-23(13)19(24)15-7-5-6-8-16(15)20(25)27-4/h5-8,11,13-14,26H,9-10,12H2,1-4H3/t13-,14-/m1/s1 OHKIQGQAIMSNQV-ZIAGYGMSSA-N 404297 Methyl 2-({(2R,5R)-5-[3-(1- hydroxy-1-methylethyl)isoxazol- 5-yl]-2-methylpiperidin-1- yl}carbonyl)benzoate::US10017504, 30 Orexin receptor type 2 Homo sapiens 251 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404297&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305897 406795060 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807758 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C21H26N2O5/c1-13-9-10-14(17-11-18(22-28-17)21(2,3)26)12-23(13)19(24)15-7-5-6-8-16(15)20(25)27-4/h5-8,11,13-14,26H,9-10,12H2,1-4H3/t13-,14-/m1/s1 OHKIQGQAIMSNQV-ZIAGYGMSSA-N 404297 Methyl 2-({(2R,5R)-5-[3-(1- hydroxy-1-methylethyl)isoxazol- 5-yl]-2-methylpiperidin-1- yl}carbonyl)benzoate::US10017504, 30 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404297&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305897 406795060 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807759 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C21H28N2O4/c1-5-26-17-9-7-6-8-16(17)20(24)23-13-15(11-10-14(23)2)18-12-19(22-27-18)21(3,4)25/h6-9,12,14-15,25H,5,10-11,13H2,1-4H3/t14-,15-/m1/s1 UONZSVLXLJZBRF-HUUCEWRRSA-N 404298 2-(5-{(3R,6R)-1-[(2- Ethoxyphenyl)carbonyl]-6- methylpiperidin-3-yl}isoxazol-3- yl)propan-2-ol::US10017504, 31 Orexin receptor type 2 Homo sapiens 178 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404298&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305859 406795061 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807760 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(no1)C(C)(C)O InChI=1S/C21H28N2O4/c1-5-26-17-9-7-6-8-16(17)20(24)23-13-15(11-10-14(23)2)18-12-19(22-27-18)21(3,4)25/h6-9,12,14-15,25H,5,10-11,13H2,1-4H3/t14-,15-/m1/s1 UONZSVLXLJZBRF-HUUCEWRRSA-N 404298 2-(5-{(3R,6R)-1-[(2- Ethoxyphenyl)carbonyl]-6- methylpiperidin-3-yl}isoxazol-3- yl)propan-2-ol::US10017504, 31 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404298&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305859 406795061 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807761 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-8-9-14(17-10-18(23-29-17)20(2,3)28)11-25(13)19(27)15-6-4-5-7-16(15)26-22-12-21-24-26/h4-7,10,12-14,28H,8-9,11H2,1-3H3/t13-,14-/m1/s1 ZYPYZPZKZGDVIP-ZIAGYGMSSA-N 404299 2-{5-[(3R,6R)-6-Methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 32 Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404299&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114431 406795062 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807762 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-8-9-14(17-10-18(23-29-17)20(2,3)28)11-25(13)19(27)15-6-4-5-7-16(15)26-22-12-21-24-26/h4-7,10,12-14,28H,8-9,11H2,1-3H3/t13-,14-/m1/s1 ZYPYZPZKZGDVIP-ZIAGYGMSSA-N 404299 2-{5-[(3R,6R)-6-Methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 32 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404299&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114431 406795062 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807763 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-c1ccccc1)c1cc(no1)C(C)(C)O InChI=1S/C24H27N3O3/c1-16-11-12-18(20-14-21(26-30-20)24(2,3)29)15-27(16)23(28)19-10-7-13-25-22(19)17-8-5-4-6-9-17/h4-10,13-14,16,18,29H,11-12,15H2,1-3H3/t16-,18-/m1/s1 DQZXDNFLKDRLGP-SJLPKXTDSA-N 404302 2-(5-{(3R,6R)-6-Methyl-1-[(2- phenylpyridin-3- yl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 33 Orexin receptor type 2 Homo sapiens 134 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404302&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305872 406795064 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807764 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1-c1ccccc1)c1cc(no1)C(C)(C)O InChI=1S/C24H27N3O3/c1-16-11-12-18(20-14-21(26-30-20)24(2,3)29)15-27(16)23(28)19-10-7-13-25-22(19)17-8-5-4-6-9-17/h4-10,13-14,16,18,29H,11-12,15H2,1-3H3/t16-,18-/m1/s1 DQZXDNFLKDRLGP-SJLPKXTDSA-N 404302 2-(5-{(3R,6R)-6-Methyl-1-[(2- phenylpyridin-3- yl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 33 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404302&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305872 406795064 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807765 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ccccc1)c1cc(no1)C(C)(C)O InChI=1S/C24H27N3O3/c1-16-11-12-18(20-14-21(26-30-20)24(2,3)29)15-27(16)23(28)22-19(10-7-13-25-22)17-8-5-4-6-9-17/h4-10,13-14,16,18,29H,11-12,15H2,1-3H3/t16-,18-/m1/s1 PHYLUQKYWWDAOY-SJLPKXTDSA-N 404303 2-(5-{(3R,6R)-6-Methyl-1-[(3- phenylpyridin-2- yl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 34 Orexin receptor type 2 Homo sapiens 264 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404303&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305929 406795065 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807766 C[C@@H]1CC[C@H](CN1C(=O)c1ncccc1-c1ccccc1)c1cc(no1)C(C)(C)O InChI=1S/C24H27N3O3/c1-16-11-12-18(20-14-21(26-30-20)24(2,3)29)15-27(16)23(28)22-19(10-7-13-25-22)17-8-5-4-6-9-17/h4-10,13-14,16,18,29H,11-12,15H2,1-3H3/t16-,18-/m1/s1 PHYLUQKYWWDAOY-SJLPKXTDSA-N 404303 2-(5-{(3R,6R)-6-Methyl-1-[(3- phenylpyridin-2- yl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 34 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404303&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305929 406795065 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807767 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OCC(F)F)c1cc(no1)C(C)(C)O InChI=1S/C21H26F2N2O4/c1-13-8-9-14(17-10-18(24-29-17)21(2,3)27)11-25(13)20(26)15-6-4-5-7-16(15)28-12-19(22)23/h4-7,10,13-14,19,27H,8-9,11-12H2,1-3H3/t13-,14-/m1/s1 ZARPXHNCLJUNCT-ZIAGYGMSSA-N 404304 2-{5-[(3R,6R)-1-{[2-(2,2- Difluoroethoxy)phenyl]carbonyl}- 6-methylpiperidin-3-yl]isoxazol- 3-yl}propan-2-ol::US10017504, 35 Orexin receptor type 2 Homo sapiens 140 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404304&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344716 406795066 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807768 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OCC(F)F)c1cc(no1)C(C)(C)O InChI=1S/C21H26F2N2O4/c1-13-8-9-14(17-10-18(24-29-17)21(2,3)27)11-25(13)20(26)15-6-4-5-7-16(15)28-12-19(22)23/h4-7,10,13-14,19,27H,8-9,11-12H2,1-3H3/t13-,14-/m1/s1 ZARPXHNCLJUNCT-ZIAGYGMSSA-N 404304 2-{5-[(3R,6R)-1-{[2-(2,2- Difluoroethoxy)phenyl]carbonyl}- 6-methylpiperidin-3-yl]isoxazol- 3-yl}propan-2-ol::US10017504, 35 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404304&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344716 406795066 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807769 CC(C)(O)c1cc(on1)[C@@H]1CCCN(C1)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C20H23F3N2O4/c1-19(2,27)17-10-16(29-24-17)13-6-5-9-25(11-13)18(26)14-7-3-4-8-15(14)28-12-20(21,22)23/h3-4,7-8,10,13,27H,5-6,9,11-12H2,1-2H3/t13-/m1/s1 QJRJGQVLTGZTRF-CYBMUJFWSA-N 404305 2-{5-[(3R,6R)-6-Methyl-1-{[2- (2,2,2-trifluoroethoxy) phenyl]carbonyl} piperidin-3-yl]isoxazol-3- yl}propan-2-ol::US10017504, 36 Orexin receptor type 2 Homo sapiens 212 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404305&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146676328 406795067 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807770 CC(C)(O)c1cc(on1)[C@@H]1CCCN(C1)C(=O)c1ccccc1OCC(F)(F)F InChI=1S/C20H23F3N2O4/c1-19(2,27)17-10-16(29-24-17)13-6-5-9-25(11-13)18(26)14-7-3-4-8-15(14)28-12-20(21,22)23/h3-4,7-8,10,13,27H,5-6,9,11-12H2,1-2H3/t13-/m1/s1 QJRJGQVLTGZTRF-CYBMUJFWSA-N 404305 2-{5-[(3R,6R)-6-Methyl-1-{[2- (2,2,2-trifluoroethoxy) phenyl]carbonyl} piperidin-3-yl]isoxazol-3- yl}propan-2-ol::US10017504, 36 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404305&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146676328 406795067 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807771 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1cnccn1)c1cc(no1)C(C)(C)O InChI=1S/C23H26N4O3/c1-15-8-9-16(20-12-21(26-30-20)23(2,3)29)14-27(15)22(28)18-7-5-4-6-17(18)19-13-24-10-11-25-19/h4-7,10-13,15-16,29H,8-9,14H2,1-3H3/t15-,16-/m1/s1 WNPQLSIYFSRITL-HZPDHXFCSA-N 404306 2-(5-{(3R,6R)-6-Methyl-1- [(2-pyrazin-2- ylphenyl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 37 Orexin receptor type 2 Homo sapiens 1034 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404306&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305891 406795068 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807772 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1cnccn1)c1cc(no1)C(C)(C)O InChI=1S/C23H26N4O3/c1-15-8-9-16(20-12-21(26-30-20)23(2,3)29)14-27(15)22(28)18-7-5-4-6-17(18)19-13-24-10-11-25-19/h4-7,10-13,15-16,29H,8-9,14H2,1-3H3/t15-,16-/m1/s1 WNPQLSIYFSRITL-HZPDHXFCSA-N 404306 2-(5-{(3R,6R)-6-Methyl-1- [(2-pyrazin-2- ylphenyl)carbonyl]piperidin-3- yl}isoxazol-3-yl)propan-2-ol::US10017504, 37 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404306&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305891 406795068 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807773 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1CC1(F)F)c1cc(no1)C(C)(C)O InChI=1S/C22H26F2N2O3/c1-13-8-9-14(18-10-19(25-29-18)21(2,3)28)12-26(13)20(27)16-7-5-4-6-15(16)17-11-22(17,23)24/h4-7,10,13-14,17,28H,8-9,11-12H2,1-3H3/t13-,14-,17?/m1/s1 BFWJJTJZXMESQY-LJNCCCJHSA-N 404307 2-{5-[(3R,6R)-1-{[2-(2,2- Difluorocyclopropyl)phenyl] carbonyl}-6-methylpiperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 38 Orexin receptor type 2 Homo sapiens 52.4 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404307&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344696 406795069 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807774 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1CC1(F)F)c1cc(no1)C(C)(C)O InChI=1S/C22H26F2N2O3/c1-13-8-9-14(18-10-19(25-29-18)21(2,3)28)12-26(13)20(27)16-7-5-4-6-15(16)17-11-22(17,23)24/h4-7,10,13-14,17,28H,8-9,11-12H2,1-3H3/t13-,14-,17?/m1/s1 BFWJJTJZXMESQY-LJNCCCJHSA-N 404307 2-{5-[(3R,6R)-1-{[2-(2,2- Difluorocyclopropyl)phenyl] carbonyl}-6-methylpiperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 38 Orexin/Hypocretin receptor type 1 Homo sapiens 7784 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404307&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344696 406795069 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807775 CC[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)C(C)(C)O InChI=1S/C22H27N5O3/c1-4-16-10-9-15(19-13-20(25-30-19)22(2,3)29)14-26(16)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-/m1/s1 ADEGLZFPNJBGHH-HZPDHXFCSA-N 404308 (2-{5-[(3R,6R)-6-Ethyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}propan-2-ol)::US10017504, 39 Orexin receptor type 2 Homo sapiens 42.4 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404308&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305877 406795070 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807776 CC[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)C(C)(C)O InChI=1S/C22H27N5O3/c1-4-16-10-9-15(19-13-20(25-30-19)22(2,3)29)14-26(16)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-/m1/s1 ADEGLZFPNJBGHH-HZPDHXFCSA-N 404308 (2-{5-[(3R,6R)-6-Ethyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}propan-2-ol)::US10017504, 39 Orexin/Hypocretin receptor type 1 Homo sapiens 2440 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404308&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305877 406795070 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807777 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C20H20F3N5O3/c1-12-6-7-13(17-10-15(26-31-17)18(29)20(21,22)23)11-27(12)19(30)14-4-2-3-5-16(14)28-24-8-9-25-28/h2-5,8-10,12-13,18,29H,6-7,11H2,1H3/t12-,13-,18-/m1/s1 IXJVJHDHSDULCH-SNUQEOBHSA-N 404309 ((1R)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol)::US10017504, 40 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404309&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114507 406795071 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807778 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C20H20F3N5O3/c1-12-6-7-13(17-10-15(26-31-17)18(29)20(21,22)23)11-27(12)19(30)14-4-2-3-5-16(14)28-24-8-9-25-28/h2-5,8-10,12-13,18,29H,6-7,11H2,1H3/t12-,13-,18-/m1/s1 IXJVJHDHSDULCH-SNUQEOBHSA-N 404309 ((1R)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol)::US10017504, 40 Orexin/Hypocretin receptor type 1 Homo sapiens 2154 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404309&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114507 406795071 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807779 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C20H20F3N5O3/c1-12-6-7-13(17-10-15(26-31-17)18(29)20(21,22)23)11-27(12)19(30)14-4-2-3-5-16(14)28-24-8-9-25-28/h2-5,8-10,12-13,18,29H,6-7,11H2,1H3/t12-,13-,18+/m1/s1 IXJVJHDHSDULCH-VFVRVIDISA-N 404310 US10017504, 41 Orexin receptor type 2 Homo sapiens 17.5 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404310&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114569 406795072 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807780 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C20H20F3N5O3/c1-12-6-7-13(17-10-15(26-31-17)18(29)20(21,22)23)11-27(12)19(30)14-4-2-3-5-16(14)28-24-8-9-25-28/h2-5,8-10,12-13,18,29H,6-7,11H2,1H3/t12-,13-,18+/m1/s1 IXJVJHDHSDULCH-VFVRVIDISA-N 404310 US10017504, 41 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404310&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114569 406795072 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807781 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-2-3-11(14-8-13(24-29-14)15(27)18(19,20)21)9-25(10)16(28)12-4-7-30-17(12)26-22-5-6-23-26/h4-8,10-11,15,27H,2-3,9H2,1H3/t10-,11-,15-/m1/s1 IYRVMSQDPFXYDV-UEKVPHQBSA-N 404311 ((1R)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol) ::US10017504, 42 Orexin receptor type 2 Homo sapiens 154 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404311&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114446 406795073 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807782 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-2-3-11(14-8-13(24-29-14)15(27)18(19,20)21)9-25(10)16(28)12-4-7-30-17(12)26-22-5-6-23-26/h4-8,10-11,15,27H,2-3,9H2,1H3/t10-,11-,15-/m1/s1 IYRVMSQDPFXYDV-UEKVPHQBSA-N 404311 ((1R)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol) ::US10017504, 42 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404311&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114446 406795073 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807783 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-2-3-11(14-8-13(24-29-14)15(27)18(19,20)21)9-25(10)16(28)12-4-7-30-17(12)26-22-5-6-23-26/h4-8,10-11,15,27H,2-3,9H2,1H3/t10-,11-,15+/m1/s1 IYRVMSQDPFXYDV-HFAKWTLXSA-N 404312 US10017504, 43 Orexin receptor type 2 Homo sapiens 162 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404312&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114539 406795074 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807784 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C18H18F3N5O3S/c1-10-2-3-11(14-8-13(24-29-14)15(27)18(19,20)21)9-25(10)16(28)12-4-7-30-17(12)26-22-5-6-23-26/h4-8,10-11,15,27H,2-3,9H2,1H3/t10-,11-,15+/m1/s1 IYRVMSQDPFXYDV-HFAKWTLXSA-N 404312 US10017504, 43 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404312&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114539 406795074 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807785 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C22H22F3N3O3/c1-13-6-7-14(18-10-17(27-31-18)19(29)22(23,24)25)11-28(13)20(30)15-4-2-3-5-16(15)21(12-26)8-9-21/h2-5,10,13-14,19,29H,6-9,11H2,1H3/t13-,14-,19-/m1/s1 CFVAZBPUVLVBJL-PJIJBLCYSA-N 404313 1-(2-{[(2R,5R)-2-Methyl-5-{3-[(1R)- 2,2,2-Trifluoro-1-hydroxyethyl]isoxazol- 5-yl}piperidin-1- yl]carbonyl}phenyl) cyclopropanecarbonitrile::US10017504, 44 Orexin receptor type 2 Homo sapiens 26.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404313&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305890 406795075 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807786 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C22H22F3N3O3/c1-13-6-7-14(18-10-17(27-31-18)19(29)22(23,24)25)11-28(13)20(30)15-4-2-3-5-16(15)21(12-26)8-9-21/h2-5,10,13-14,19,29H,6-9,11H2,1H3/t13-,14-,19-/m1/s1 CFVAZBPUVLVBJL-PJIJBLCYSA-N 404313 1-(2-{[(2R,5R)-2-Methyl-5-{3-[(1R)- 2,2,2-Trifluoro-1-hydroxyethyl]isoxazol- 5-yl}piperidin-1- yl]carbonyl}phenyl) cyclopropanecarbonitrile::US10017504, 44 Orexin/Hypocretin receptor type 1 Homo sapiens 2183 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404313&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305890 406795075 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807787 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C22H22F3N3O3/c1-13-6-7-14(18-10-17(27-31-18)19(29)22(23,24)25)11-28(13)20(30)15-4-2-3-5-16(15)21(12-26)8-9-21/h2-5,10,13-14,19,29H,6-9,11H2,1H3/t13-,14-,19+/m1/s1 CFVAZBPUVLVBJL-LPMFXHHGSA-N 404314 1-(2-{[(2R,5R)-2-Methyl-5-{3-[(1S)- 2,2,2-trifluoro-1-hydroxyethyl]isoxazol- 5-yl}piperidin-1-yl]carbonyl} phenyl)cyclopropanecarbonitrile::US10017504, 45 Orexin receptor type 2 Homo sapiens 41.2 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404314&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305881 406795076 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807788 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C22H22F3N3O3/c1-13-6-7-14(18-10-17(27-31-18)19(29)22(23,24)25)11-28(13)20(30)15-4-2-3-5-16(15)21(12-26)8-9-21/h2-5,10,13-14,19,29H,6-9,11H2,1H3/t13-,14-,19+/m1/s1 CFVAZBPUVLVBJL-LPMFXHHGSA-N 404314 1-(2-{[(2R,5R)-2-Methyl-5-{3-[(1S)- 2,2,2-trifluoro-1-hydroxyethyl]isoxazol- 5-yl}piperidin-1-yl]carbonyl} phenyl)cyclopropanecarbonitrile::US10017504, 45 Orexin/Hypocretin receptor type 1 Homo sapiens 3418 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404314&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305881 406795076 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807789 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-8-14(25-31-16)17(29)19(20,21)22)9-27(11)18(30)13-4-2-3-5-15(13)28-24-10-23-26-28/h2-5,8,10-12,17,29H,6-7,9H2,1H3/t11-,12-,17-/m1/s1 XXUYQYODNGKFQF-PSTGCABASA-N 404315 (1R)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6- methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}ethanol::US10017504, 46 Orexin receptor type 2 Homo sapiens 356 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404315&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114613 406795077 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807790 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-8-14(25-31-16)17(29)19(20,21)22)9-27(11)18(30)13-4-2-3-5-15(13)28-24-10-23-26-28/h2-5,8,10-12,17,29H,6-7,9H2,1H3/t11-,12-,17-/m1/s1 XXUYQYODNGKFQF-PSTGCABASA-N 404315 (1R)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6- methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}ethanol::US10017504, 46 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404315&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114613 406795077 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807791 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-8-14(25-31-16)17(29)19(20,21)22)9-27(11)18(30)13-4-2-3-5-15(13)28-24-10-23-26-28/h2-5,8,10-12,17,29H,6-7,9H2,1H3/t11-,12-,17+/m1/s1 XXUYQYODNGKFQF-QFSBIZTOSA-N 404316 (1S)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6- methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}ethanol::US10017504, 47 Orexin receptor type 2 Homo sapiens 328 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404316&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114665 406795078 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807792 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-8-14(25-31-16)17(29)19(20,21)22)9-27(11)18(30)13-4-2-3-5-15(13)28-24-10-23-26-28/h2-5,8,10-12,17,29H,6-7,9H2,1H3/t11-,12-,17+/m1/s1 XXUYQYODNGKFQF-QFSBIZTOSA-N 404316 (1S)-2,2,2-Trifluoro-1-{5-[(3R,6R)-6- methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}ethanol::US10017504, 47 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404316&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114665 406795078 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807793 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C20H19F3N4O3S/c1-11-3-4-12(15-9-14(26-30-15)17(28)20(21,22)23)10-27(11)19(29)13-5-8-31-16(13)18-24-6-2-7-25-18/h2,5-9,11-12,17,28H,3-4,10H2,1H3/t11-,12-,17-/m1/s1 WHCFQFSWDCGLFE-PSTGCABASA-N 404317 ((1S)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 48) and ((1R)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 49)::US10017504, 48 Orexin receptor type 2 Homo sapiens 113 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404317&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315914 406795079 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807794 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C20H19F3N4O3S/c1-11-3-4-12(15-9-14(26-30-15)17(28)20(21,22)23)10-27(11)19(29)13-5-8-31-16(13)18-24-6-2-7-25-18/h2,5-9,11-12,17,28H,3-4,10H2,1H3/t11-,12-,17-/m1/s1 WHCFQFSWDCGLFE-PSTGCABASA-N 404317 ((1S)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 48) and ((1R)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 49)::US10017504, 48 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404317&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315914 406795079 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807795 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C20H19F3N4O3S/c1-11-3-4-12(15-9-14(26-30-15)17(28)20(21,22)23)10-27(11)19(29)13-5-8-31-16(13)18-24-6-2-7-25-18/h2,5-9,11-12,17,28H,3-4,10H2,1H3/t11-,12-,17-/m1/s1 WHCFQFSWDCGLFE-PSTGCABASA-N 404318 (1R)-2,2,2-trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol ::US10017504, 49 Orexin receptor type 2 Homo sapiens 112 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404318&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315914 406795080 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807796 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1cc(no1)[C@@H](O)C(F)(F)F InChI=1S/C20H19F3N4O3S/c1-11-3-4-12(15-9-14(26-30-15)17(28)20(21,22)23)10-27(11)19(29)13-5-8-31-16(13)18-24-6-2-7-25-18/h2,5-9,11-12,17,28H,3-4,10H2,1H3/t11-,12-,17-/m1/s1 WHCFQFSWDCGLFE-PSTGCABASA-N 404318 (1R)-2,2,2-trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol ::US10017504, 49 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404318&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315914 406795080 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807797 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C22H21F3N4O3/c1-13-7-8-14(18-11-17(28-32-18)19(30)22(23,24)25)12-29(13)21(31)16-6-3-2-5-15(16)20-26-9-4-10-27-20/h2-6,9-11,13-14,19,30H,7-8,12H2,1H3/t13-,14-,19+/m1/s1 DXXYQCKWGKWEOC-LPMFXHHGSA-N 404319 ((1R)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 50) and ((1S)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 51)::US10017504, 50 Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404319&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121316005 406795081 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807798 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C22H21F3N4O3/c1-13-7-8-14(18-11-17(28-32-18)19(30)22(23,24)25)12-29(13)21(31)16-6-3-2-5-15(16)20-26-9-4-10-27-20/h2-6,9-11,13-14,19,30H,7-8,12H2,1H3/t13-,14-,19+/m1/s1 DXXYQCKWGKWEOC-LPMFXHHGSA-N 404319 ((1R)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 50) and ((1S)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol) (Ex. 51)::US10017504, 50 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404319&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121316005 406795081 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807799 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C22H21F3N4O3/c1-13-7-8-14(18-11-17(28-32-18)19(30)22(23,24)25)12-29(13)21(31)16-6-3-2-5-15(16)20-26-9-4-10-27-20/h2-6,9-11,13-14,19,30H,7-8,12H2,1H3/t13-,14-,19+/m1/s1 DXXYQCKWGKWEOC-LPMFXHHGSA-N 404320 ((1S)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol)::US10017504, 51 Orexin receptor type 2 Homo sapiens 146 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404320&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121316005 406795082 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807800 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(no1)[C@H](O)C(F)(F)F InChI=1S/C22H21F3N4O3/c1-13-7-8-14(18-11-17(28-32-18)19(30)22(23,24)25)12-29(13)21(31)16-6-3-2-5-15(16)20-26-9-4-10-27-20/h2-6,9-11,13-14,19,30H,7-8,12H2,1H3/t13-,14-,19+/m1/s1 DXXYQCKWGKWEOC-LPMFXHHGSA-N 404320 ((1S)-2,2,2-Trifluoro-1-(5-{(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}isoxazol-3-yl)ethanol)::US10017504, 51 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404320&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121316005 406795082 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807801 CON(C)C(=O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H24N6O4/c1-14-8-9-15(19-12-17(24-31-19)21(29)25(2)30-3)13-26(14)20(28)16-6-4-5-7-18(16)27-22-10-11-23-27/h4-7,10-12,14-15H,8-9,13H2,1-3H3/t14-,15-/m1/s1 MIBXPEQHKVZDQE-HUUCEWRRSA-N 404321 (1-Cyclopropyl-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol) (Ex. 52) and (1-Cyclopropyl-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol) (Ex. 53)::US10017504, 52 Orexin receptor type 2 Homo sapiens 47.3 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404321&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114577 406795083 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807802 CON(C)C(=O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H24N6O4/c1-14-8-9-15(19-12-17(24-31-19)21(29)25(2)30-3)13-26(14)20(28)16-6-4-5-7-18(16)27-22-10-11-23-27/h4-7,10-12,14-15H,8-9,13H2,1-3H3/t14-,15-/m1/s1 MIBXPEQHKVZDQE-HUUCEWRRSA-N 404321 (1-Cyclopropyl-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol) (Ex. 52) and (1-Cyclopropyl-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol) (Ex. 53)::US10017504, 52 Orexin/Hypocretin receptor type 1 Homo sapiens 2364 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404321&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114577 406795083 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807803 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)C(C)(O)C1CC1 InChI=1S/C23H27N5O3/c1-15-7-8-16(20-13-21(26-31-20)23(2,30)17-9-10-17)14-27(15)22(29)18-5-3-4-6-19(18)28-24-11-12-25-28/h3-6,11-13,15-17,30H,7-10,14H2,1-2H3/t15-,16-,23?/m1/s1 YNUXBLHTOPWHEA-LHVRJDQKSA-N 404322 1-cyclopropyl-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol::US10017504, 53 Orexin receptor type 2 Homo sapiens 34.3 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404322&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344748 406795084 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807804 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)C(C)(O)C1CC1 InChI=1S/C23H27N5O3/c1-15-7-8-16(20-13-21(26-31-20)23(2,30)17-9-10-17)14-27(15)22(29)18-5-3-4-6-19(18)28-24-11-12-25-28/h3-6,11-13,15-17,30H,7-10,14H2,1-2H3/t15-,16-,23?/m1/s1 YNUXBLHTOPWHEA-LHVRJDQKSA-N 404322 1-cyclopropyl-1-{5-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isoxazol-3-yl}ethanol::US10017504, 53 Orexin/Hypocretin receptor type 1 Homo sapiens 3084 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404322&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344748 406795084 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807805 CCC(C)(O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-19(30-25-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22?/m1/s1 UTMQUUSZJLGJDB-AXJGWOQESA-N 404323 2-{5-[(3R,6R)-6-Methyl-1- {[2-(2H-1,2,3- triazol-2-yl)phenyl] carbonyl}piperidin-3- yl]isoxazol-3-yl}butan-2-ol::US10017504, 54::US10017504, 55 Orexin receptor type 2 Homo sapiens 76.1 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404323&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114514 406795085 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807806 CCC(C)(O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-19(30-25-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22?/m1/s1 UTMQUUSZJLGJDB-AXJGWOQESA-N 404323 2-{5-[(3R,6R)-6-Methyl-1- {[2-(2H-1,2,3- triazol-2-yl)phenyl] carbonyl}piperidin-3- yl]isoxazol-3-yl}butan-2-ol::US10017504, 54::US10017504, 55 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404323&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114514 406795085 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807807 CCC(C)(O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-19(30-25-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22?/m1/s1 UTMQUUSZJLGJDB-AXJGWOQESA-N 404323 2-{5-[(3R,6R)-6-Methyl-1- {[2-(2H-1,2,3- triazol-2-yl)phenyl] carbonyl}piperidin-3- yl]isoxazol-3-yl}butan-2-ol::US10017504, 54::US10017504, 55 Orexin receptor type 2 Homo sapiens 39.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404323&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114514 406795085 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807808 CCC(C)(O)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-4-22(3,29)20-13-19(30-25-20)16-10-9-15(2)26(14-16)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16,29H,4,9-10,14H2,1-3H3/t15-,16-,22?/m1/s1 UTMQUUSZJLGJDB-AXJGWOQESA-N 404323 2-{5-[(3R,6R)-6-Methyl-1- {[2-(2H-1,2,3- triazol-2-yl)phenyl] carbonyl}piperidin-3- yl]isoxazol-3-yl}butan-2-ol::US10017504, 54::US10017504, 55 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404323&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114514 406795085 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807809 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)C1CCCO1 InChI=1S/C22H25N5O3/c1-15-8-9-16(21-13-18(25-30-21)20-7-4-12-29-20)14-26(15)22(28)17-5-2-3-6-19(17)27-23-10-11-24-27/h2-3,5-6,10-11,13,15-16,20H,4,7-9,12,14H2,1H3/t15-,16-,20?/m1/s1 CVQHCVDZWWKPIZ-KFKFVUQKSA-N 404325 ((2R,5R)-2-Methyl-5-[3-(tetrahydrofuran-2-yl)isoxazol-5-yl]-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10017504, 56 Orexin receptor type 2 Homo sapiens 311 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404325&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121316030 406795086 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807810 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(no1)C1CCCO1 InChI=1S/C22H25N5O3/c1-15-8-9-16(21-13-18(25-30-21)20-7-4-12-29-20)14-26(15)22(28)17-5-2-3-6-19(17)27-23-10-11-24-27/h2-3,5-6,10-11,13,15-16,20H,4,7-9,12,14H2,1H3/t15-,16-,20?/m1/s1 CVQHCVDZWWKPIZ-KFKFVUQKSA-N 404325 ((2R,5R)-2-Methyl-5-[3-(tetrahydrofuran-2-yl)isoxazol-5-yl]-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10017504, 56 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404325&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121316030 406795086 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807811 COC(C)(C)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-15-9-10-16(19-13-20(25-30-19)22(2,3)29-4)14-26(15)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16H,9-10,14H2,1-4H3/t15-,16-/m1/s1 NGLUPPLYZRRKAO-HZPDHXFCSA-N 404326 ((2R,5R)-5-[3-(1-Methoxy-1-methylethyl)isoxazol-5-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine)::US10017504, 57 Orexin receptor type 2 Homo sapiens 14.4 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404326&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315889 406795087 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807812 COC(C)(C)c1cc(on1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H27N5O3/c1-15-9-10-16(19-13-20(25-30-19)22(2,3)29-4)14-26(15)21(28)17-7-5-6-8-18(17)27-23-11-12-24-27/h5-8,11-13,15-16H,9-10,14H2,1-4H3/t15-,16-/m1/s1 NGLUPPLYZRRKAO-HZPDHXFCSA-N 404326 ((2R,5R)-5-[3-(1-Methoxy-1-methylethyl)isoxazol-5-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine)::US10017504, 57 Orexin/Hypocretin receptor type 1 Homo sapiens 1030 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404326&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315889 406795087 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807813 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H25N5O2S/c1-14-8-9-15(17-12-19(29-24-17)21(2,3)28)13-25(14)20(27)16-6-4-5-7-18(16)26-22-10-11-23-26/h4-7,10-12,14-15,28H,8-9,13H2,1-3H3/t14-,15-/m1/s1 QQUUPCCXIMNVNU-HUUCEWRRSA-N 404327 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isothiazol-5-yl}propan-2-ol::US10017504, 58 Orexin receptor type 2 Homo sapiens 13.9 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404327&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121315980 406795088 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807814 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H25N5O2S/c1-14-8-9-15(17-12-19(29-24-17)21(2,3)28)13-25(14)20(27)16-6-4-5-7-18(16)26-22-10-11-23-26/h4-7,10-12,14-15,28H,8-9,13H2,1-3H3/t14-,15-/m1/s1 QQUUPCCXIMNVNU-HUUCEWRRSA-N 404327 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]isothiazol-5-yl}propan-2-ol::US10017504, 58 Orexin/Hypocretin receptor type 1 Homo sapiens 8306 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404327&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121315980 406795088 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807815 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1cc(sn1)C(C)(C)O InChI=1S/C19H23N5O2S2/c1-12-4-5-13(15-10-16(28-22-15)19(2,3)26)11-23(12)17(25)14-6-9-27-18(14)24-20-7-8-21-24/h6-10,12-13,26H,4-5,11H2,1-3H3/t12-,13-/m1/s1 CLZSKYPWRDGDGO-CHWSQXEVSA-N 404328 (2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl]carbonyl}piperidin-3-yl]isothiazol-5-yl}propan-2-ol)::US10017504, 59 Orexin receptor type 2 Homo sapiens 24.9 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404328&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121316074 406795089 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807816 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1cc(sn1)C(C)(C)O InChI=1S/C19H23N5O2S2/c1-12-4-5-13(15-10-16(28-22-15)19(2,3)26)11-23(12)17(25)14-6-9-27-18(14)24-20-7-8-21-24/h6-10,12-13,26H,4-5,11H2,1-3H3/t12-,13-/m1/s1 CLZSKYPWRDGDGO-CHWSQXEVSA-N 404328 (2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl]carbonyl}piperidin-3-yl]isothiazol-5-yl}propan-2-ol)::US10017504, 59 Orexin/Hypocretin receptor type 1 Homo sapiens 3963 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404328&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121316074 406795089 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807817 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(sn1)C(C)(C)O InChI=1S/C20H24N6O2S/c1-13-8-9-14(16-10-18(29-23-16)20(2,3)28)11-25(13)19(27)15-6-4-5-7-17(15)26-22-12-21-24-26/h4-7,10,12-14,28H,8-9,11H2,1-3H3/t13-,14-/m1/s1 VRMRTHCKXNXHQE-ZIAGYGMSSA-N 404329 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-tetrazol- 2-yl)phenyl]carbonyl}piperidin-3- yl]isothiazol-5-yl}propan-2-ol::US10017504, 60 Orexin receptor type 2 Homo sapiens 63.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404329&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132114545 406795090 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807818 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(sn1)C(C)(C)O InChI=1S/C20H24N6O2S/c1-13-8-9-14(16-10-18(29-23-16)20(2,3)28)11-25(13)19(27)15-6-4-5-7-17(15)26-22-12-21-24-26/h4-7,10,12-14,28H,8-9,11H2,1-3H3/t13-,14-/m1/s1 VRMRTHCKXNXHQE-ZIAGYGMSSA-N 404329 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-tetrazol- 2-yl)phenyl]carbonyl}piperidin-3- yl]isothiazol-5-yl}propan-2-ol::US10017504, 60 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404329&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132114545 406795090 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807819 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H24FN5O2S/c1-13-4-5-14(17-11-19(30-25-17)21(2,3)29)12-26(13)20(28)16-7-6-15(22)10-18(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 AJNMLNUBNXEABO-ZIAGYGMSSA-N 404330 2-{3-[(3R,6R)-1-{[4-Fluoro-2-(2H-1,2,3- triazol-2-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isothiazol-5-yl} propan-2-ol::US10017504, 61 Orexin receptor type 2 Homo sapiens 18.6 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404330&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344737 406795091 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807820 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H24FN5O2S/c1-13-4-5-14(17-11-19(30-25-17)21(2,3)29)12-26(13)20(28)16-7-6-15(22)10-18(16)27-23-8-9-24-27/h6-11,13-14,29H,4-5,12H2,1-3H3/t13-,14-/m1/s1 AJNMLNUBNXEABO-ZIAGYGMSSA-N 404330 2-{3-[(3R,6R)-1-{[4-Fluoro-2-(2H-1,2,3- triazol-2-yl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isothiazol-5-yl} propan-2-ol::US10017504, 61 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404330&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344737 406795091 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807821 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(sn1)C(C)(C)O InChI=1S/C23H27N3O2S/c1-15-8-9-16(19-12-20(29-25-19)22(2,3)28)13-26(15)21(27)17-6-4-5-7-18(17)23(14-24)10-11-23/h4-7,12,15-16,28H,8-11,13H2,1-3H3/t15-,16-/m1/s1 BOLIVFQLBGTMBL-HZPDHXFCSA-N 404331 1-[2-({(2R,5R)-5-[5-(1-Hydroxy-1- methylethyl)isothiazol-3-yl]-2- methylpiperidin-1-yl} carbonyl)phenyl]cyclopropanecarbonitrile::US10017504, 62 Orexin receptor type 2 Homo sapiens 19.1 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404331&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305867 406795092 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807822 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1cc(sn1)C(C)(C)O InChI=1S/C23H27N3O2S/c1-15-8-9-16(19-12-20(29-25-19)22(2,3)28)13-26(15)21(27)17-6-4-5-7-18(17)23(14-24)10-11-23/h4-7,12,15-16,28H,8-11,13H2,1-3H3/t15-,16-/m1/s1 BOLIVFQLBGTMBL-HZPDHXFCSA-N 404331 1-[2-({(2R,5R)-5-[5-(1-Hydroxy-1- methylethyl)isothiazol-3-yl]-2- methylpiperidin-1-yl} carbonyl)phenyl]cyclopropanecarbonitrile::US10017504, 62 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404331&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305867 406795092 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807823 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(sn1)C(C)(C)O InChI=1S/C23H26N4O2S/c1-15-9-10-16(19-13-20(30-26-19)23(2,3)29)14-27(15)22(28)18-8-5-4-7-17(18)21-24-11-6-12-25-21/h4-8,11-13,15-16,29H,9-10,14H2,1-3H3/t15-,16-/m1/s1 VHOHJOJHFZPBSX-HZPDHXFCSA-N 404332 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2- ylphenyl)carbonyl]piperidin-3-yl}isothiazol- 5-yl)propan-2-ol::US10017504, 63 Orexin receptor type 2 Homo sapiens 42.3 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404332&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305901 406795093 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807824 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1cc(sn1)C(C)(C)O InChI=1S/C23H26N4O2S/c1-15-9-10-16(19-13-20(30-26-19)23(2,3)29)14-27(15)22(28)18-8-5-4-7-17(18)21-24-11-6-12-25-21/h4-8,11-13,15-16,29H,9-10,14H2,1-3H3/t15-,16-/m1/s1 VHOHJOJHFZPBSX-HZPDHXFCSA-N 404332 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2- ylphenyl)carbonyl]piperidin-3-yl}isothiazol- 5-yl)propan-2-ol::US10017504, 63 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404332&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305901 406795093 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807825 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H24N4O2S2/c1-13-5-6-14(16-11-17(29-24-16)21(2,3)27)12-25(13)20(26)15-7-10-28-18(15)19-22-8-4-9-23-19/h4,7-11,13-14,27H,5-6,12H2,1-3H3/t13-,14-/m1/s1 KYODEAJBALCMIQ-ZIAGYGMSSA-N 404333 (2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isothiazol-5-yl)propan-2-ol)::US10017504, 64 Orexin receptor type 2 Homo sapiens 36.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404333&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305856 406795094 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807826 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H24N4O2S2/c1-13-5-6-14(16-11-17(29-24-16)21(2,3)27)12-25(13)20(26)15-7-10-28-18(15)19-22-8-4-9-23-19/h4,7-11,13-14,27H,5-6,12H2,1-3H3/t13-,14-/m1/s1 KYODEAJBALCMIQ-ZIAGYGMSSA-N 404333 (2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}isothiazol-5-yl)propan-2-ol)::US10017504, 64 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404333&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305856 406795094 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807827 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H24N4O2S2/c1-13-5-6-14(17-9-18(29-24-17)21(2,3)27)10-25(13)20(26)16-12-28-11-15(16)19-22-7-4-8-23-19/h4,7-9,11-14,27H,5-6,10H2,1-3H3/t13-,14-/m1/s1 OYWCMARTFTYRDK-ZIAGYGMSSA-N 404334 2-(3-{(3R,6R)-6-Methyl-1-[(4-pyrimidin-2- ylthiophen-3-yl)carbonyl]piperidin-3- yl}isothiazol-5-yl)propan-2-ol::US10017504, 65 Orexin receptor type 2 Homo sapiens 46.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404334&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305888 406795095 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807828 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)c1cc(sn1)C(C)(C)O InChI=1S/C21H24N4O2S2/c1-13-5-6-14(17-9-18(29-24-17)21(2,3)27)10-25(13)20(26)16-12-28-11-15(16)19-22-7-4-8-23-19/h4,7-9,11-14,27H,5-6,10H2,1-3H3/t13-,14-/m1/s1 OYWCMARTFTYRDK-ZIAGYGMSSA-N 404334 2-(3-{(3R,6R)-6-Methyl-1-[(4-pyrimidin-2- ylthiophen-3-yl)carbonyl]piperidin-3- yl}isothiazol-5-yl)propan-2-ol::US10017504, 65 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404334&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305888 406795095 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807829 CC(C)(O)c1cc(ns1)[C@@H]1CCCN(C1)C(=O)c1cscc1-n1nccn1 InChI=1S/C18H21N5O2S2/c1-18(2,25)16-8-14(21-27-16)12-4-3-7-22(9-12)17(24)13-10-26-11-15(13)23-19-5-6-20-23/h5-6,8,10-12,25H,3-4,7,9H2,1-2H3/t12-/m1/s1 BEJVWMBQGPDIEO-GFCCVEGCSA-N 404335 2-{3-[(3R,6R)-6-Methyl-1-{[4-(2H-1,2,3- triazol-2-yl)thiophen-3-yl]carbonyl} piperidin-3-yl]isothiazol-5- yl}propan-2-ol::US10017504, 66 Orexin receptor type 2 Homo sapiens 21.1 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404335&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146676329 406795096 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807830 CC(C)(O)c1cc(ns1)[C@@H]1CCCN(C1)C(=O)c1cscc1-n1nccn1 InChI=1S/C18H21N5O2S2/c1-18(2,25)16-8-14(21-27-16)12-4-3-7-22(9-12)17(24)13-10-26-11-15(13)23-19-5-6-20-23/h5-6,8,10-12,25H,3-4,7,9H2,1-2H3/t12-/m1/s1 BEJVWMBQGPDIEO-GFCCVEGCSA-N 404335 2-{3-[(3R,6R)-6-Methyl-1-{[4-(2H-1,2,3- triazol-2-yl)thiophen-3-yl]carbonyl} piperidin-3-yl]isothiazol-5- yl}propan-2-ol::US10017504, 66 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404335&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146676329 406795096 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807831 COC(=O)c1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(sn1)C(C)(C)O InChI=1S/C20H25N3O4S/c1-12-7-8-13(15-10-16(28-22-15)20(2,3)26)11-23(12)18(24)14-6-5-9-21-17(14)19(25)27-4/h5-6,9-10,12-13,26H,7-8,11H2,1-4H3/t12-,13-/m1/s1 OFYXIDJHTMJOTD-CHWSQXEVSA-N 404336 Methyl 2-({(2R,5R)-5-[5-(1-hydroxy-1- methylethyl)isothiazol-3-yl]-2- methylpiperidin-1-yl}carbonyl)benzoate::US10017504, 67 Orexin receptor type 2 Homo sapiens 43.6 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404336&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146676330 406795097 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807832 COC(=O)c1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(sn1)C(C)(C)O InChI=1S/C20H25N3O4S/c1-12-7-8-13(15-10-16(28-22-15)20(2,3)26)11-23(12)18(24)14-6-5-9-21-17(14)19(25)27-4/h5-6,9-10,12-13,26H,7-8,11H2,1-4H3/t12-,13-/m1/s1 OFYXIDJHTMJOTD-CHWSQXEVSA-N 404336 Methyl 2-({(2R,5R)-5-[5-(1-hydroxy-1- methylethyl)isothiazol-3-yl]-2- methylpiperidin-1-yl}carbonyl)benzoate::US10017504, 67 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404336&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146676330 406795097 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807833 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)c1cc(sn1)C(C)(C)O InChI=1S/C20H24F3N3O3S/c1-12-6-7-13(15-9-16(30-25-15)19(2,3)28)10-26(12)18(27)14-5-4-8-24-17(14)29-11-20(21,22)23/h4-5,8-9,12-13,28H,6-7,10-11H2,1-3H3/t12-,13-/m1/s1 ILESPBYNBQEYIU-CHWSQXEVSA-N 404337 2-{3-[(3R,6R)-6-Methyl-1-{[2- (trifluoromethoxy)phenyl] carbonyl}piperidin-3-yl] isothiazol-5-yl}propan-2-ol::US10017504, 68 Orexin receptor type 2 Homo sapiens 22.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404337&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 146676331 406795098 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807834 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)c1cc(sn1)C(C)(C)O InChI=1S/C20H24F3N3O3S/c1-12-6-7-13(15-9-16(30-25-15)19(2,3)28)10-26(12)18(27)14-5-4-8-24-17(14)29-11-20(21,22)23/h4-5,8-9,12-13,28H,6-7,10-11H2,1-3H3/t12-,13-/m1/s1 ILESPBYNBQEYIU-CHWSQXEVSA-N 404337 2-{3-[(3R,6R)-6-Methyl-1-{[2- (trifluoromethoxy)phenyl] carbonyl}piperidin-3-yl] isothiazol-5-yl}propan-2-ol::US10017504, 68 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404337&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 146676331 406795098 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807835 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)c1cc(sn1)C(C)(C)O InChI=1S/C20H25F2N3O3S/c1-12-6-7-13(15-9-16(29-24-15)20(2,3)27)10-25(12)19(26)14-5-4-8-23-18(14)28-11-17(21)22/h4-5,8-9,12-13,17,27H,6-7,10-11H2,1-3H3/t12-,13-/m1/s1 XXFKWOLUHIOORO-CHWSQXEVSA-N 404338 2-{3-[(3R,6R)-1-{[2-(2,2- Difluoroethoxy)pyridin-3-yl]carbonyl}-6- methylpiperidin-3-yl]isothiazol- 5-yl}propan-2-ol::US10017504, 69 Orexin receptor type 2 Homo sapiens 42.8 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404338&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344691 406795099 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807836 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)F)c1cc(sn1)C(C)(C)O InChI=1S/C20H25F2N3O3S/c1-12-6-7-13(15-9-16(29-24-15)20(2,3)27)10-25(12)19(26)14-5-4-8-23-18(14)28-11-17(21)22/h4-5,8-9,12-13,17,27H,6-7,10-11H2,1-3H3/t12-,13-/m1/s1 XXFKWOLUHIOORO-CHWSQXEVSA-N 404338 2-{3-[(3R,6R)-1-{[2-(2,2- Difluoroethoxy)pyridin-3-yl]carbonyl}-6- methylpiperidin-3-yl]isothiazol- 5-yl}propan-2-ol::US10017504, 69 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404338&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344691 406795099 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 807837 COCCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(sn1)C(C)(C)O InChI=1S/C22H30N2O3S/c1-15-9-10-17(19-13-20(28-23-19)22(2,3)26)14-24(15)21(25)18-8-6-5-7-16(18)11-12-27-4/h5-8,13,15,17,26H,9-12,14H2,1-4H3/t15-,17-/m1/s1 DLZSPZLWFNDKRA-NVXWUHKLSA-N 404339 2-{3-[(3R,6R)-1-{[2-(2- methoxyethyl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isothiazol-5- yl}propan-2-ol::US10017504, 70 Orexin receptor type 2 Homo sapiens 935 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404339&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344699 406795100 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 807838 COCCc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1cc(sn1)C(C)(C)O InChI=1S/C22H30N2O3S/c1-15-9-10-17(19-13-20(28-23-19)22(2,3)26)14-24(15)21(25)18-8-6-5-7-16(18)11-12-27-4/h5-8,13,15,17,26H,9-12,14H2,1-4H3/t15-,17-/m1/s1 DLZSPZLWFNDKRA-NVXWUHKLSA-N 404339 2-{3-[(3R,6R)-1-{[2-(2- methoxyethyl)phenyl]carbonyl}-6- methylpiperidin-3-yl]isothiazol-5- yl}propan-2-ol::US10017504, 70 Orexin/Hypocretin receptor type 1 Homo sapiens >10000 US Patent 10.7270/Q24F1T30 aid1799526 US10017504 Liverton, N; Kuduk, SD; Beshore, D; Luo, Y; Meng, N; Yu, T 7/10/2018 6/1/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=404339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=404339&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344699 406795100 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6